Gandhi, S., Warltier, D., Weiskopf, R., Bepperling, F., Baus, D., & Jungheinrich, C. (2005). Volume substitution therapy with HES 130/0.4 (Voluven(®)) versus HES 450/0.7 (hetastarch) during major orthopedic surgery. BioMed Central.
シカゴスタイル引用形Gandhi, S., D. Warltier, R. Weiskopf, F. Bepperling, D. Baus, , C. Jungheinrich. Volume Substitution Therapy With HES 130/0.4 (Voluven(®)) Versus HES 450/0.7 (hetastarch) During Major Orthopedic Surgery. BioMed Central, 2005.
MLA引用形式Gandhi, S., et al. Volume Substitution Therapy With HES 130/0.4 (Voluven(®)) Versus HES 450/0.7 (hetastarch) During Major Orthopedic Surgery. BioMed Central, 2005.
警告: この引用は必ずしも正確ではありません.